U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Incomprehensible speech

MedGen UID:
333001
Concept ID:
C1838027
Finding
HPO: HP:0002546

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • Incomprehensible speech

Conditions with this feature

Childhood apraxia of speech
MedGen UID:
152917
Concept ID:
C0750927
Mental or Behavioral Dysfunction
All FOXP2-related speech and language disorders, regardless of the underlying genetic alteration, have a core phenotype: childhood apraxia of speech (CAS), a disorder of speech motor programming or planning that affects the production, sequencing, timing, and stress of sounds, syllables, and words. All individuals with CAS – whether caused by an alteration of FOXP2 or of an unknown cause – have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with the correct prosody. Additional findings in FOXP2-related speech and language disorders can include oral motor dyspraxia (difficulty planning or programming oral movements on command); dysarthria (a neuromuscular-based speech disorder that may affect nasal resonance, voice quality, prosody, and breath support for speech); moderate to severe receptive and expressive language disorder; and reading and spelling impairments. The underlying genetic cause of FOXP2-related speech and language disorders is either disruption of FOXP2 only (referred to in this GeneReview as FOXP2-only-related speech and language disorder) or large copy number variants (i.e., contiguous gene deletions), structural variants (i.e., chromosome translocation or inversion), or maternal uniparental disomy of chromosome 7 (UPD7) involving FOXP2 (here referred to as FOXP2-plus-related speech and language disorders). The genetic alteration determines if only speech and language problems are present (FOXP2-only-related speech and language disorder) or if more global developmental and behavioral issues are likely to be present as well (FOXP2-plus-related speech and language disorder). In FOXP2-only-related disorders, nonverbal (performance) IQ is typically more preserved compared to verbal IQ. Fine motor skills may be impaired (e.g., buttoning clothes, tying shoelaces), yet gross motor skills are normal. Autistic features and dysmorphic findings have been reported in a few affected individuals. In FOXP2-plus-related disorders oral motor deficits, global developmental delay, and autism spectrum disorder are common.
Intellectual disability, autosomal recessive 3
MedGen UID:
373870
Concept ID:
C1838023
Mental or Behavioral Dysfunction
Any autosomal recessive non-syndromic intellectual disability in which the cause of the disease is a mutation in the CC2D1A gene.
Optic atrophy 11
MedGen UID:
934595
Concept ID:
C4310628
Disease or Syndrome
Optic atrophy-11 (OPA11) is an autosomal recessive disorder characterized by delayed psychomotor development, intellectual disability, ataxia, optic atrophy, and leukoencephalopathy on brain imaging. Laboratory studies are consistent with mitochondrial dysfunction (summary by Hartmann et al., 2016). For a discussion of genetic heterogeneity of optic atrophy, see OPA1 (165500).

Recent clinical studies

Etiology

Rupert J, Hughes P, Schoenherr D
Am Fam Physician 2023 Aug;108(2):181-188. PMID: 37590860
Sjögreen L, Mårtensson Å, Ekström AB
Int J Lang Commun Disord 2018 May;53(3):576-583. Epub 2018 Jan 12 doi: 10.1111/1460-6984.12370. PMID: 29327796
Lai YC, Chia YY, Lien WH
Pain Physician 2017 Mar;20(3):E465-E468. PMID: 28339449
Bakhshani NM, Hosseinbore N, Kianpoor M
Asian J Psychiatr 2013 Dec;6(6):566-70. Epub 2013 Oct 9 doi: 10.1016/j.ajp.2013.09.012. PMID: 24309874
Robson J, Marshall J, Chiat S, Pring T
Int J Lang Commun Disord 2001 Oct-Dec;36(4):471-88. doi: 10.1080/13682820110089371. PMID: 11802498

Diagnosis

Rupert J, Hughes P, Schoenherr D
Am Fam Physician 2023 Aug;108(2):181-188. PMID: 37590860
Magee CD, Parsons AS, Millard AS, Torre D
Diagnosis (Berl) 2021 Aug 30;9(1):127-132. doi: 10.1515/dx-2020-0096. PMID: 34455730
Raol N, Hartnick CJ
Adv Otorhinolaryngol 2015;76:1-6. Epub 2015 Feb 19 doi: 10.1159/000368003. PMID: 25733226
Akhtar S, Rai MK, Dutta TK, Subrahmanyam D, Adithan C
J Postgrad Med 2010 Jan-Mar;56(1):42-3. doi: 10.4103/0022-3859.62423. PMID: 20393254

Therapy

Puffay C, Vanthornhout J, Gillis M, Clercq P, Accou B, Hamme HV, Francart T
Sci Rep 2024 Aug 14;14(1):18922. doi: 10.1038/s41598-024-69568-0. PMID: 39143297Free PMC Article
Akhtar S, Rai MK, Dutta TK, Subrahmanyam D, Adithan C
J Postgrad Med 2010 Jan-Mar;56(1):42-3. doi: 10.4103/0022-3859.62423. PMID: 20393254
Hong SB, Joo EY, Tae WS, Cho JW, Lee JH, Seo DW, Suh YL, Hong SC
Seizure 2008 Jun;17(4):383-6. Epub 2007 Sep 4 doi: 10.1016/j.seizure.2007.07.014. PMID: 17768074

Prognosis

Lai YC, Chia YY, Lien WH
Pain Physician 2017 Mar;20(3):E465-E468. PMID: 28339449
Akhtar S, Rai MK, Dutta TK, Subrahmanyam D, Adithan C
J Postgrad Med 2010 Jan-Mar;56(1):42-3. doi: 10.4103/0022-3859.62423. PMID: 20393254

Clinical prediction guides

Puffay C, Vanthornhout J, Gillis M, Clercq P, Accou B, Hamme HV, Francart T
Sci Rep 2024 Aug 14;14(1):18922. doi: 10.1038/s41598-024-69568-0. PMID: 39143297Free PMC Article
Rupert J, Hughes P, Schoenherr D
Am Fam Physician 2023 Aug;108(2):181-188. PMID: 37590860
Sjögreen L, Mårtensson Å, Ekström AB
Int J Lang Commun Disord 2018 May;53(3):576-583. Epub 2018 Jan 12 doi: 10.1111/1460-6984.12370. PMID: 29327796
Bakhshani NM, Hosseinbore N, Kianpoor M
Asian J Psychiatr 2013 Dec;6(6):566-70. Epub 2013 Oct 9 doi: 10.1016/j.ajp.2013.09.012. PMID: 24309874
Robson J, Marshall J, Chiat S, Pring T
Int J Lang Commun Disord 2001 Oct-Dec;36(4):471-88. doi: 10.1080/13682820110089371. PMID: 11802498

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...